A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection

Journal of Clinical Gastroenterology

Volumn 34, Issue 3, 2002, Pages 268-271

  Muir, Andrew J ^a   Provenzale, Dawn ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hepatitis C; Interferon alfa; Substance related disorders; Veterans

Indexed keywords

ALPHA INTERFERON;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEGRO; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; SEX DIFFERENCE; SOLDIER; SUBSTANCE ABUSE;

ADULT; ANTIVIRAL AGENTS; ELIGIBILITY DETERMINATION; EVALUATION STUDIES; FEMALE; HEPATITIS C, CHRONIC; HOSPITALS, VETERANS; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VETERANS;

EID: 0036179441     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200203000-00015     Document Type: Article

References (26)

1. Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
2. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
3. Peginterferon alfa-2a in patients with chronic hepatitis C
4. Peginterferon alfa-2b plus ribavirin compared with interferon, alfa-2b plus ribavirin for intial treatment of chronic hepatitis C: A randomised trial
5. Epidemiology of hepatitis C virus infection in American veterans
6. Seroepidemiology of hepatitis C and B in an urban VA medical center
7. Hepatitis C in African Americans: Summary of a workshop
8. The impact of pegylated interferon alfa-2b on health-related quality of life in chronic hepatitis C patients
9. The CES-D scale: A self-report depression scale for research in the general population
10. Validation of the Center for Epidemiological Studies Scale (CES-D) in hepatitis C patients
11. From clinical research to secondary prevention: International collaboration in the development of the Alcohol Use Disorders Identification Test (AUDIT)
12. Hepatitis C, interferon alfa, and depression
13. Clinical profile of chronic hepatitis C in US veterans in comparison with non-veterans
14. Influence of psychiatric diagnoses on interferon-α treatment for chronic hepatitis C infection
15. Natural history of liver fibrosis progression in patients with chronic hepatitis C
16. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection
17. Impact of alcohol on the histological and clinical progression of hepatitis C infection
18. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis
19. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers
20. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the epidemiologic catchment study
21. Hepatitis C virus and depression in drug users
22. How often are referred chronic hepatitis C patients eligible for antiviral therapy?
23. Psychiatric disorders in hepatitis C virus related chronic liver disease
24. Morbidity of chronic hepatitis C as seen in a tertiary care medical center
25. Hepatitis C and depression